Mouse models of ATP8A2 deficiency have demonstrated that Atp8a2 mutations result in impaired axonal transport, axonal loss, failure to thrive and clinical manifestations of neurodegenerative disease which are similar to the patients we describe [7]. This evidence concerns the gene ATP8A2 and Failure to thrive.